|
Abdomen
|
A01.923.047 |
|
|
Hypokalemic Periodic Paralysis
|
D020514 |
[An autosomal dominant familial disorder characterized by recurrent episodes of skeletal muscle weakness associated with falls in serum potassium levels. The condition usually presents in the first or second decade of life with attacks of trunk and leg paresis during sleep or shortly after awakening. Symptoms may persist for hours to days and generally are precipitated by exercise or a meal high in carbohydrates. (Adams et al., Principles of Neurology, 6th ed, p1483)
] |
|
Herpesvirus 4, Bovine
|
B04.280.382.400.700.300 |
|
|
Myopathy, Central Core
|
D020512 |
[An inherited congenital myopathic condition characterized by weakness and hypotonia in infancy and delayed motor development. Muscle biopsy reveals a condensation of myofibrils and myofibrillar material in the central portion of each muscle fiber. (Adams et al., Principles of Neurology, 6th ed, p1452)
] |
|
Paralysis, Hyperkalemic Periodic
|
D020513 |
[An autosomal dominant familial disorder which presents in infancy or childhood and is characterized by episodes of weakness associated with hyperkalemia. During attacks, muscles of the lower extremities are initially affected, followed by the lower trunk and arms. Episodes last from 15-60 minutes and typically occur after a period of rest following exercise. A defect in skeletal muscle sodium channels has been identified as the cause of this condition. Normokalemic periodic paralysis is a closely related disorder marked by a lack of alterations in potassium levels during attacks of weakness. (Adams et al., Principles of Neurology, 6th ed, p1481)
] |
|
Killer Cells, Lymphokine-Activated
|
A15.145.229.637.555.567.537.500 |
|
|
Killer Cells, Natural
|
A15.145.229.637.555.567.537 |
|
|
Floxuridine
|
D03.383.742.680.852.300.350 |
|
|
Neuromuscular Junction Diseases
|
D020511 |
[Conditions characterized by impaired transmission of impulses at the NEUROMUSCULAR JUNCTION. This may result from disorders that affect receptor function, pre- or postsynaptic membrane function, or ACETYLCHOLINESTERASE activity. The majority of diseases in this category are associated with autoimmune, toxic, or inherited conditions.
] |
|
Postprandial Period
|
D019518 |
[The time frame after a meal or FOOD INTAKE.
] |
|
Focal Nodular Hyperplasia
|
D020518 |
[Solitary or multiple benign hepatic vascular tumors, usually occurring in women of 20-50 years of age. The nodule, poorly encapsulated, consists of a central stellate fibrous scar and normal liver elements such as HEPATOCYTES, small BILE DUCTS, and KUPFFER CELLS among the intervening fibrous septa. The pale colored central scar represents large blood vessels with hyperplastic fibromuscular layer and narrowing lumen.
] |
|
Flunarizine
|
D03.383.606.450 |
|
|
Poster
|
D019519 |
[Work consisting of single or multi-sheet notices made to attract attention to events, activities, causes, goods, or services. They are for posting, usually in a public place and are chiefly pictorial. They are intended to make an immediate impression from a distance. Posters do not include poster presentations at conferences and meetings. (From Thesaurus for Graphic Materials II: Genre and Physical Characteristic Headings, 1995)
] |
|
Pericardiocentesis
|
D020519 |
[Puncture and aspiration of fluid from the PERICARDIUM.
] |
|
Brachial Plexus Neuropathies
|
D020516 |
[Diseases of the cervical (and first thoracic) roots, nerve trunks, cords, and peripheral nerve components of the BRACHIAL PLEXUS. Clinical manifestations include regional pain, PARESTHESIA; MUSCLE WEAKNESS, and decreased sensation (HYPESTHESIA) in the upper extremity. These disorders may be associated with trauma (including BIRTH INJURIES); THORACIC OUTLET SYNDROME; NEOPLASMS; NEURITIS; RADIOTHERAPY; and other conditions. (From Adams et al., Principles of Neurology, 6th ed, pp1351-2)
] |
|
Heliotropium
|
B01.650.940.800.575.912.250.150.444 |
|
|
Atrial Appendage
|
D020517 |
[Ear-shaped appendage of either atrium of the heart. (Dorland, 28th ed)
] |
|
Menopause
|
G08.686.157.500 |
|
|
Climacteric
|
G08.686.157 |
|
|
Cyclic Nucleotide Phosphodiesterases, Type 2
|
D12.776.476.009.200 |
|